Measuring Size and Shape Heterogeneity in AAVs with Ion Mobility Mass Spectrometry

10 January 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Adeno-associated viruses (AAVs) are at the forefront of biopharmaceutical development as gene therapy vectors. The successful approval of these medicines requires robust characterization including an assessment of therapeutic gene content. Using ion mobility–mass spectrometry (IM-MS) techniques, we determine empty:full capsid ratios and explore structural differences in AAV particles relevant to payload. With drift tube IM-MS, we demonstrate that empty capsids, while slightly smaller, present more conformational variability than full capsids. This method also resolves two partially filled capsid species with intermediate masses, between that of empty and full capsids wherein the lower mass feature is conformationally more like empty and the higher mass feature appears highly similar to the full capsid. We present data using travelling wave ion mobility (TWIM) operated under conditions that limit or favour the mass-to-charge ratio (m/z) dependence on ion transit time through the drift cell via the velocity relaxation effect. This permits separation of empty and full capsids in the absence of mass spectrometry information, providing a new approach to study conformational and mass differences in super massive particles.

Keywords

AAV
Ion Mobility Mass Spectrometry
Structural Biology

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
Supporting Information
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.